1) ceptopril
酰托普利
1.
Pharmacokinetic studies of ceptopril in healthy male and female volunteers;
酰托普利在健康男、女受试者体内的药代动力学研究
2.
Effects of Ceptopril on Human Monocyte Chemoattractant Protein-1 and Blood Pressure;
单核细胞趋化蛋白-1对血压与酰托普利治疗的影响
2) captopril
卡托普利
1.
Determination of diffusion coefficients of captopril in aqueous solution;
药物卡托普利在水溶液中扩散系数的测定
2.
Determination of underivatized captopril by capillary electrophoresis;
未衍生化卡托普利的毛细管电泳法测定
3.
Determination of Content and Related Substance of Captopril Tablet;
卡托普利片含量及有关物质测定方法
3) Pentopril
喷托普利
4) Captopril Tablets
卡托普利片
1.
Determination of Captopril Tablets by HPLC;
HPLC法测定卡托普利片含量
2.
Conclusion:This method is simple,convenient,specific and is suitable for the quality control of Captopril tablets.
目的:建立离子选择性电极法测定卡托普利片含量的新方法。
5) Compound Captopril Tablets
复方卡托普利
1.
Simultaneous Content Determination and Uniformity of Content in Compound Captopril Tablets by HPLC;
HPLC法同时测定复方卡托普利片中主药含量及含量均匀度
6) intravenous captopril
静脉卡托普利
1.
Objective:It is to observe the clinical effects of intravenous captopril in treating congestive heart failure.
目的 :观察开富林 (静脉卡托普利 )治疗充血性心力衰竭的临床疗效。
补充资料：利托君
分子式：C17H21NO3
分子量：287.36
CAS号：26652-09-5
性质：白色结晶。熔点88-90℃。
制备方法：暂无
用途：暂无
分子量：287.36
CAS号：26652-09-5
性质：白色结晶。熔点88-90℃。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条